JT-08

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameJT-08
Drug Alias NameJT08
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-X-C motif chemokine receptor 5 antagonists
TargetsC-X-C motif chemokine receptor 5
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJyant Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJyant Technologies
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A